semaglutide patent expiry date With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are What is the patent landscape

78-LB: Efficacy and Safety of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Compared With Insulin Degludec in Patients With Type 2 Diabetes (SURPASS-3)

Lancet 368 , 11061118 (2006)

Clinical trial data shows nausea affects between 15.4% to 43.9% of users depending on dose and formulation, with higher doses producing increased incidence

We offer a completely free virtual medical consultation where our dedicated weight management specialists will thoroughly review your comprehensive health history, current body mass index (BMI), weight loss goals, and prior wellness efforts to safely construct your personalized care roadmap.

This product is Halal certified